Prolonged ILD may result in pulmonary fibrosis, but this is not always the case. Idiopathic pulmonary fibrosis is interstitial lung disease for which no obvious cause can be identified (idiopathic), and is associated with typical radiographic (basal and pleural based fibrosis with honeycombing) and pathologic (temporally and spatially heterogeneous fibrosis, histopathologic honeycombing and fibroblastic foci) findings.
Causes
ILD may be classified according to the cause. One method of classification is as follows:
The study of respiratory disease is known as pulmonology. A doctor who specializes in respiratory disease is known as a pulmonologist, a chest medicine specialist, a respiratory medicine specialist, a respirologist or a thoracic medicine specialist.
UBET
Respiratory diseases can be classified in many different ways, including by the organ or tissue involved, by the type and pattern of associated signs and symptoms, or by the cause (aetiology) of the disease.
Interstitial Lung Disease (ILD) - Classification, pathophysiology, signs and symptoms
Where do I get my information from: http://armandoh.org/resource
"Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group of disorders based on similar clinical, radiographic, physiologic, and pathologic changes.
Present primarily with shortness of breath and a non productive cough usually chronic over weeks to months without response to initial treatment of puffers. If there is clinical suspicion of ILD a full pulmonary function test should be done. Characteristic changes of ILD include: reduced total lung capacity (TLC) and DLCO.
The diffuse parenchymal lung diseases are divided into those that are associated with known causes or unknown causes and other weird and wonderful rare causes."
🎥 DON'T JUST WATCH, LEARN ACTIVELY! TRY THE QUIZ! 🤓
https...
published: 17 Jan 2021
Interstitial Lung Disease (ILD) in a Nutshell
An overview of ILD (also known as diffuse parenchymal lung diseases), including definition, classification, etiologies, and diagnostic evaluation (e.g. CT and PFT findings).
This video “Interstitial Lung Disease (ILD): Overview” is part of the Lecturio course “Interstitial Lung Disease” ► WATCH the complete course on http://lectur.io/ildyoutube
► LEARN ABOUT:
- classification of interstital lung disease
► THE PROF: Professor Jeremy Brown is a clinician scientist with an interest in respiratory infection. He studied medicine in London, graduating with honors, and continued his postgraduate medical training in a variety of London hospitals. He completed his PhD in molecular microbiology in 1999 and obtained a prestigious Welcome Advanced Research Fellowship for further scientific training at the University of Adelaide. His research is mainly focused on respiratory complications of haematological disease and stem cell transplantation. His educational and scien...
Please read and agree to the disclaimer before watching this video.
. Subscribe to the drbeen Channel HERE: http://bit.ly/2GBhiS0
For more content from drbeen, click HERE: http://bit.ly/2GB41bU
Watch drbeen videos HERE: http://bit.ly/2GB41bU
Like drbeen on Facebook HERE: http://bit.ly/2GSSTGS
Follow drbeen on Twitter HERE: http://bit.ly/2XeSVhV
Follow drbeen on Instagram HERE: http://bit.ly/2ST2Zih
Get new medical lectures across your devices. Stream anywhere, anytime. Try it for free! http://bit.ly/2QsIwQ5
This video presents the introduction to restrictive lung diseases. We will discuss:
Definition
Types
Extrapulmonary restrictive lung diseases
* Obesity
* Scoliosis
Pulmonary parenchymal restrictive lung diseases
* Idiopathic
* Autoimmune
* Granulomatous (Wagner's granulomatosis, Sar...
published: 03 Dec 2017
Interstitial lung disease, Causes, Signs and Symptoms, Diagnosis and Treatment
.
Chapters
0:00 Introduction
1:18 Causes of Interstitial lung disease
3:13 Symptoms and Diagnosis of Interstitial lung disease
3:53 Treatment of Interstitial lung disease.
Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD),[3] is a group of respiratory diseases affecting the interstitium (the tissue and space around the alveoli (air sacs) of the lungs.[4] It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. It may occur when an injury to the lungs triggers an abnormal healing response. Ordinarily, the body generates just the right amount of tissue to repair damage, but in interstitial lung disease, the repair process is disrupted, and the tissue around the air sacs (alveoli) becomes sc...
published: 31 Jan 2021
Interstitial Lung Disease
Interstitial lung disease or ILD is an autoimmune condition of the lung. In some people, the body will attack itself and when it happens in the lung, it is a problem. Once the body begins to attack the lung, you become more short of breath. This video will tell you why.
Where do I get my information from: http://armandoh.org/resource
"Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group...
Where do I get my information from: http://armandoh.org/resource
"Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group of disorders based on similar clinical, radiographic, physiologic, and pathologic changes.
Present primarily with shortness of breath and a non productive cough usually chronic over weeks to months without response to initial treatment of puffers. If there is clinical suspicion of ILD a full pulmonary function test should be done. Characteristic changes of ILD include: reduced total lung capacity (TLC) and DLCO.
The diffuse parenchymal lung diseases are divided into those that are associated with known causes or unknown causes and other weird and wonderful rare causes."
🎥 DON'T JUST WATCH, LEARN ACTIVELY! TRY THE QUIZ! 🤓
https://youmakr.ai/test-playground/questionnaire/673d32a1859b9c170836ea51
👆Hit this quiz and show of your main character aura!
Support me:
🖼️ Buy PDFs: http://armandoh.org/shop
💵 Patreon: http://www.patreon.com/armando
👕 Buy shirts: https://teespring.com/stores/ah-7
Social media:
📷 Instagram: http://instagram.com/armandohasudungan
🐦 Twitter: https://twitter.com/armandohasudung
📔 Facebook: https://www.facebook.com/ArmandoHasudungan
Resources:
📕 Books: http://armandoh.org/resource
🎞️ Equipment: armandoh.org/armando-faigl
You can send me mail:
📫 PO BOX 166, Randwick NSW 2031, Australia
Where do I get my information from: http://armandoh.org/resource
"Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group of disorders based on similar clinical, radiographic, physiologic, and pathologic changes.
Present primarily with shortness of breath and a non productive cough usually chronic over weeks to months without response to initial treatment of puffers. If there is clinical suspicion of ILD a full pulmonary function test should be done. Characteristic changes of ILD include: reduced total lung capacity (TLC) and DLCO.
The diffuse parenchymal lung diseases are divided into those that are associated with known causes or unknown causes and other weird and wonderful rare causes."
🎥 DON'T JUST WATCH, LEARN ACTIVELY! TRY THE QUIZ! 🤓
https://youmakr.ai/test-playground/questionnaire/673d32a1859b9c170836ea51
👆Hit this quiz and show of your main character aura!
Support me:
🖼️ Buy PDFs: http://armandoh.org/shop
💵 Patreon: http://www.patreon.com/armando
👕 Buy shirts: https://teespring.com/stores/ah-7
Social media:
📷 Instagram: http://instagram.com/armandohasudungan
🐦 Twitter: https://twitter.com/armandohasudung
📔 Facebook: https://www.facebook.com/ArmandoHasudungan
Resources:
📕 Books: http://armandoh.org/resource
🎞️ Equipment: armandoh.org/armando-faigl
You can send me mail:
📫 PO BOX 166, Randwick NSW 2031, Australia
An overview of ILD (also known as diffuse parenchymal lung diseases), including definition, classification, etiologies, and diagnostic evaluation (e.g. CT and P...
An overview of ILD (also known as diffuse parenchymal lung diseases), including definition, classification, etiologies, and diagnostic evaluation (e.g. CT and PFT findings).
An overview of ILD (also known as diffuse parenchymal lung diseases), including definition, classification, etiologies, and diagnostic evaluation (e.g. CT and PFT findings).
This video “Interstitial Lung Disease (ILD): Overview” is part of the Lecturio course “Interstitial Lung Disease” ► WATCH the complete course on http://lectur.i...
This video “Interstitial Lung Disease (ILD): Overview” is part of the Lecturio course “Interstitial Lung Disease” ► WATCH the complete course on http://lectur.io/ildyoutube
► LEARN ABOUT:
- classification of interstital lung disease
► THE PROF: Professor Jeremy Brown is a clinician scientist with an interest in respiratory infection. He studied medicine in London, graduating with honors, and continued his postgraduate medical training in a variety of London hospitals. He completed his PhD in molecular microbiology in 1999 and obtained a prestigious Welcome Advanced Research Fellowship for further scientific training at the University of Adelaide. His research is mainly focused on respiratory complications of haematological disease and stem cell transplantation. His educational and scientific experience enables him to teach students and professionals about respiratory medicine.
►LECTURIO is your single-point resource for medical school:
Study for your classes, USMLE Step 1, USMLE Step 2, MCAT or MBBS with video lectures by world-class professors, recall & USMLE-style questions and textbook articles. Create your free account here: http://lectur.io/ildyoutube
► INSTALL our free Lecturio app
iTunes Store: https://app.adjust.com/z21zrf
Play Store: https://app.adjust.com/b01fak
► READ TEXTBOOK ARTICLES related to this video: Interstitial Lung Disease (ILD) — Types and Symptoms
http://lectur.io/ildarticle
► SUBSCRIBE to our YouTube channel: http://lectur.io/subscribe
► WATCH MORE ON YOUTUBE: http://lectur.io/playlists
► LET’S CONNECT:
• Facebook: https://www.facebook.com/lecturio.medical.education.videos
• Instagram: https://www.instagram.com/lecturio_medical_videos
This video “Interstitial Lung Disease (ILD): Overview” is part of the Lecturio course “Interstitial Lung Disease” ► WATCH the complete course on http://lectur.io/ildyoutube
► LEARN ABOUT:
- classification of interstital lung disease
► THE PROF: Professor Jeremy Brown is a clinician scientist with an interest in respiratory infection. He studied medicine in London, graduating with honors, and continued his postgraduate medical training in a variety of London hospitals. He completed his PhD in molecular microbiology in 1999 and obtained a prestigious Welcome Advanced Research Fellowship for further scientific training at the University of Adelaide. His research is mainly focused on respiratory complications of haematological disease and stem cell transplantation. His educational and scientific experience enables him to teach students and professionals about respiratory medicine.
►LECTURIO is your single-point resource for medical school:
Study for your classes, USMLE Step 1, USMLE Step 2, MCAT or MBBS with video lectures by world-class professors, recall & USMLE-style questions and textbook articles. Create your free account here: http://lectur.io/ildyoutube
► INSTALL our free Lecturio app
iTunes Store: https://app.adjust.com/z21zrf
Play Store: https://app.adjust.com/b01fak
► READ TEXTBOOK ARTICLES related to this video: Interstitial Lung Disease (ILD) — Types and Symptoms
http://lectur.io/ildarticle
► SUBSCRIBE to our YouTube channel: http://lectur.io/subscribe
► WATCH MORE ON YOUTUBE: http://lectur.io/playlists
► LET’S CONNECT:
• Facebook: https://www.facebook.com/lecturio.medical.education.videos
• Instagram: https://www.instagram.com/lecturio_medical_videos
Please read and agree to the disclaimer before watching this video.
. Subscribe to the drbeen Channel HERE: http://bit.ly/2GBhiS0
For more content from drbeen, ...
Please read and agree to the disclaimer before watching this video.
. Subscribe to the drbeen Channel HERE: http://bit.ly/2GBhiS0
For more content from drbeen, click HERE: http://bit.ly/2GB41bU
Watch drbeen videos HERE: http://bit.ly/2GB41bU
Like drbeen on Facebook HERE: http://bit.ly/2GSSTGS
Follow drbeen on Twitter HERE: http://bit.ly/2XeSVhV
Follow drbeen on Instagram HERE: http://bit.ly/2ST2Zih
Get new medical lectures across your devices. Stream anywhere, anytime. Try it for free! http://bit.ly/2QsIwQ5
This video presents the introduction to restrictive lung diseases. We will discuss:
Definition
Types
Extrapulmonary restrictive lung diseases
* Obesity
* Scoliosis
Pulmonary parenchymal restrictive lung diseases
* Idiopathic
* Autoimmune
* Granulomatous (Wagner's granulomatosis, Sarcoidosis)
* Occupational (pneumoconiosis, silicosis, asbestosis, coal, etc.)
* Other irritants
* Chronic infections (Tuberculosis)
Neuromuscular restrictive lung diseases
* Myasthenia gravis
* Diaphragm issues
* Polio
Cellular events/pathogenesis
* Damaged Type I Pneumocytes
* Hypertrophy of Type II Pneumocytes
* Irritated epithelium
* Irritated macrophages
* Apoptosis of epithelium
* Tissue damage leading to local inflammation and lung destruction/scaring.
* Neutrophils releasing cytokines, proteases, tumor growth factors (TGF)
* Macrophages releasing transforming growth factor beta, tumor necrosis factor (TNF), platelet activation factor.
* Fibroblasts overactivity resulting in more extracellular matrix and hardening.
* Epithelial-mesenchymal transformation.
* Smooth muscle proliferation.
* Respiratory interface thickening. Disrupted gaseous exchange.
Clinical:
Dry hacking cough
* Dyspnea
* Hypoxia
* Respiratory alkalosis
* Late inspiratory crackles
Abnormal chest X-Ray
* Reduced volume in chest X-Ray
* Lower lobes show more involvement and the reason why.
* Right heart failure/cor pulmonale
Lung Function Changes
* FEV1/FVC ratio increases above 80% (normal or above normal)
Treatment
* Anti-inflammatory (may not be very effective)
* TGF Beta-blockers
* Oxygen
* Lung transplant ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
Please read and agree to the disclaimer before watching this video.
. Subscribe to the drbeen Channel HERE: http://bit.ly/2GBhiS0
For more content from drbeen, click HERE: http://bit.ly/2GB41bU
Watch drbeen videos HERE: http://bit.ly/2GB41bU
Like drbeen on Facebook HERE: http://bit.ly/2GSSTGS
Follow drbeen on Twitter HERE: http://bit.ly/2XeSVhV
Follow drbeen on Instagram HERE: http://bit.ly/2ST2Zih
Get new medical lectures across your devices. Stream anywhere, anytime. Try it for free! http://bit.ly/2QsIwQ5
This video presents the introduction to restrictive lung diseases. We will discuss:
Definition
Types
Extrapulmonary restrictive lung diseases
* Obesity
* Scoliosis
Pulmonary parenchymal restrictive lung diseases
* Idiopathic
* Autoimmune
* Granulomatous (Wagner's granulomatosis, Sarcoidosis)
* Occupational (pneumoconiosis, silicosis, asbestosis, coal, etc.)
* Other irritants
* Chronic infections (Tuberculosis)
Neuromuscular restrictive lung diseases
* Myasthenia gravis
* Diaphragm issues
* Polio
Cellular events/pathogenesis
* Damaged Type I Pneumocytes
* Hypertrophy of Type II Pneumocytes
* Irritated epithelium
* Irritated macrophages
* Apoptosis of epithelium
* Tissue damage leading to local inflammation and lung destruction/scaring.
* Neutrophils releasing cytokines, proteases, tumor growth factors (TGF)
* Macrophages releasing transforming growth factor beta, tumor necrosis factor (TNF), platelet activation factor.
* Fibroblasts overactivity resulting in more extracellular matrix and hardening.
* Epithelial-mesenchymal transformation.
* Smooth muscle proliferation.
* Respiratory interface thickening. Disrupted gaseous exchange.
Clinical:
Dry hacking cough
* Dyspnea
* Hypoxia
* Respiratory alkalosis
* Late inspiratory crackles
Abnormal chest X-Ray
* Reduced volume in chest X-Ray
* Lower lobes show more involvement and the reason why.
* Right heart failure/cor pulmonale
Lung Function Changes
* FEV1/FVC ratio increases above 80% (normal or above normal)
Treatment
* Anti-inflammatory (may not be very effective)
* TGF Beta-blockers
* Oxygen
* Lung transplant ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
.
Chapters
0:00 Introduction
1:18 Causes of Interstitial lung disease
3:13 Symptoms and Diagnosis of Interstitial lung disease
3:53 Treatment of Interstitial ...
.
Chapters
0:00 Introduction
1:18 Causes of Interstitial lung disease
3:13 Symptoms and Diagnosis of Interstitial lung disease
3:53 Treatment of Interstitial lung disease.
Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD),[3] is a group of respiratory diseases affecting the interstitium (the tissue and space around the alveoli (air sacs) of the lungs.[4] It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. It may occur when an injury to the lungs triggers an abnormal healing response. Ordinarily, the body generates just the right amount of tissue to repair damage, but in interstitial lung disease, the repair process is disrupted, and the tissue around the air sacs (alveoli) becomes scarred and thickened. This makes it more difficult for oxygen to pass into the bloodstream. The disease presents itself with the following symptoms: shortness of breath, nonproductive coughing, fatigue, and weight loss, which tend to develop slowly, over several months. The average rate of survival for someone with this disease is between three and five years.[5] The term ILD is used to distinguish these diseases from obstructive airways diseases.
There are specific types in children, known as children's interstitial lung diseases. The acronym ChILD is sometimes used for this group of diseases.[6]
Prolonged ILD may result in pulmonary fibrosis, but this is not always the case. Idiopathic pulmonary fibrosis is interstitial lung disease for which no obvious cause can be identified (idiopathic) and is associated with typical findings both radiographic (basal and pleural-based fibrosis with honeycombing) and pathologic (temporally and spatially heterogeneous fibrosis, histopathologic honeycombing, and fibroblastic foci).
.
Chapters
0:00 Introduction
1:18 Causes of Interstitial lung disease
3:13 Symptoms and Diagnosis of Interstitial lung disease
3:53 Treatment of Interstitial lung disease.
Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD),[3] is a group of respiratory diseases affecting the interstitium (the tissue and space around the alveoli (air sacs) of the lungs.[4] It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. It may occur when an injury to the lungs triggers an abnormal healing response. Ordinarily, the body generates just the right amount of tissue to repair damage, but in interstitial lung disease, the repair process is disrupted, and the tissue around the air sacs (alveoli) becomes scarred and thickened. This makes it more difficult for oxygen to pass into the bloodstream. The disease presents itself with the following symptoms: shortness of breath, nonproductive coughing, fatigue, and weight loss, which tend to develop slowly, over several months. The average rate of survival for someone with this disease is between three and five years.[5] The term ILD is used to distinguish these diseases from obstructive airways diseases.
There are specific types in children, known as children's interstitial lung diseases. The acronym ChILD is sometimes used for this group of diseases.[6]
Prolonged ILD may result in pulmonary fibrosis, but this is not always the case. Idiopathic pulmonary fibrosis is interstitial lung disease for which no obvious cause can be identified (idiopathic) and is associated with typical findings both radiographic (basal and pleural-based fibrosis with honeycombing) and pathologic (temporally and spatially heterogeneous fibrosis, histopathologic honeycombing, and fibroblastic foci).
Interstitial lung disease or ILD is an autoimmune condition of the lung. In some people, the body will attack itself and when it happens in the lung, it is a p...
Interstitial lung disease or ILD is an autoimmune condition of the lung. In some people, the body will attack itself and when it happens in the lung, it is a problem. Once the body begins to attack the lung, you become more short of breath. This video will tell you why.
Interstitial lung disease or ILD is an autoimmune condition of the lung. In some people, the body will attack itself and when it happens in the lung, it is a problem. Once the body begins to attack the lung, you become more short of breath. This video will tell you why.
Where do I get my information from: http://armandoh.org/resource
"Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group of disorders based on similar clinical, radiographic, physiologic, and pathologic changes.
Present primarily with shortness of breath and a non productive cough usually chronic over weeks to months without response to initial treatment of puffers. If there is clinical suspicion of ILD a full pulmonary function test should be done. Characteristic changes of ILD include: reduced total lung capacity (TLC) and DLCO.
The diffuse parenchymal lung diseases are divided into those that are associated with known causes or unknown causes and other weird and wonderful rare causes."
🎥 DON'T JUST WATCH, LEARN ACTIVELY! TRY THE QUIZ! 🤓
https://youmakr.ai/test-playground/questionnaire/673d32a1859b9c170836ea51
👆Hit this quiz and show of your main character aura!
Support me:
🖼️ Buy PDFs: http://armandoh.org/shop
💵 Patreon: http://www.patreon.com/armando
👕 Buy shirts: https://teespring.com/stores/ah-7
Social media:
📷 Instagram: http://instagram.com/armandohasudungan
🐦 Twitter: https://twitter.com/armandohasudung
📔 Facebook: https://www.facebook.com/ArmandoHasudungan
Resources:
📕 Books: http://armandoh.org/resource
🎞️ Equipment: armandoh.org/armando-faigl
You can send me mail:
📫 PO BOX 166, Randwick NSW 2031, Australia
An overview of ILD (also known as diffuse parenchymal lung diseases), including definition, classification, etiologies, and diagnostic evaluation (e.g. CT and PFT findings).
This video “Interstitial Lung Disease (ILD): Overview” is part of the Lecturio course “Interstitial Lung Disease” ► WATCH the complete course on http://lectur.io/ildyoutube
► LEARN ABOUT:
- classification of interstital lung disease
► THE PROF: Professor Jeremy Brown is a clinician scientist with an interest in respiratory infection. He studied medicine in London, graduating with honors, and continued his postgraduate medical training in a variety of London hospitals. He completed his PhD in molecular microbiology in 1999 and obtained a prestigious Welcome Advanced Research Fellowship for further scientific training at the University of Adelaide. His research is mainly focused on respiratory complications of haematological disease and stem cell transplantation. His educational and scientific experience enables him to teach students and professionals about respiratory medicine.
►LECTURIO is your single-point resource for medical school:
Study for your classes, USMLE Step 1, USMLE Step 2, MCAT or MBBS with video lectures by world-class professors, recall & USMLE-style questions and textbook articles. Create your free account here: http://lectur.io/ildyoutube
► INSTALL our free Lecturio app
iTunes Store: https://app.adjust.com/z21zrf
Play Store: https://app.adjust.com/b01fak
► READ TEXTBOOK ARTICLES related to this video: Interstitial Lung Disease (ILD) — Types and Symptoms
http://lectur.io/ildarticle
► SUBSCRIBE to our YouTube channel: http://lectur.io/subscribe
► WATCH MORE ON YOUTUBE: http://lectur.io/playlists
► LET’S CONNECT:
• Facebook: https://www.facebook.com/lecturio.medical.education.videos
• Instagram: https://www.instagram.com/lecturio_medical_videos
Please read and agree to the disclaimer before watching this video.
. Subscribe to the drbeen Channel HERE: http://bit.ly/2GBhiS0
For more content from drbeen, click HERE: http://bit.ly/2GB41bU
Watch drbeen videos HERE: http://bit.ly/2GB41bU
Like drbeen on Facebook HERE: http://bit.ly/2GSSTGS
Follow drbeen on Twitter HERE: http://bit.ly/2XeSVhV
Follow drbeen on Instagram HERE: http://bit.ly/2ST2Zih
Get new medical lectures across your devices. Stream anywhere, anytime. Try it for free! http://bit.ly/2QsIwQ5
This video presents the introduction to restrictive lung diseases. We will discuss:
Definition
Types
Extrapulmonary restrictive lung diseases
* Obesity
* Scoliosis
Pulmonary parenchymal restrictive lung diseases
* Idiopathic
* Autoimmune
* Granulomatous (Wagner's granulomatosis, Sarcoidosis)
* Occupational (pneumoconiosis, silicosis, asbestosis, coal, etc.)
* Other irritants
* Chronic infections (Tuberculosis)
Neuromuscular restrictive lung diseases
* Myasthenia gravis
* Diaphragm issues
* Polio
Cellular events/pathogenesis
* Damaged Type I Pneumocytes
* Hypertrophy of Type II Pneumocytes
* Irritated epithelium
* Irritated macrophages
* Apoptosis of epithelium
* Tissue damage leading to local inflammation and lung destruction/scaring.
* Neutrophils releasing cytokines, proteases, tumor growth factors (TGF)
* Macrophages releasing transforming growth factor beta, tumor necrosis factor (TNF), platelet activation factor.
* Fibroblasts overactivity resulting in more extracellular matrix and hardening.
* Epithelial-mesenchymal transformation.
* Smooth muscle proliferation.
* Respiratory interface thickening. Disrupted gaseous exchange.
Clinical:
Dry hacking cough
* Dyspnea
* Hypoxia
* Respiratory alkalosis
* Late inspiratory crackles
Abnormal chest X-Ray
* Reduced volume in chest X-Ray
* Lower lobes show more involvement and the reason why.
* Right heart failure/cor pulmonale
Lung Function Changes
* FEV1/FVC ratio increases above 80% (normal or above normal)
Treatment
* Anti-inflammatory (may not be very effective)
* TGF Beta-blockers
* Oxygen
* Lung transplant ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
.
Chapters
0:00 Introduction
1:18 Causes of Interstitial lung disease
3:13 Symptoms and Diagnosis of Interstitial lung disease
3:53 Treatment of Interstitial lung disease.
Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD),[3] is a group of respiratory diseases affecting the interstitium (the tissue and space around the alveoli (air sacs) of the lungs.[4] It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. It may occur when an injury to the lungs triggers an abnormal healing response. Ordinarily, the body generates just the right amount of tissue to repair damage, but in interstitial lung disease, the repair process is disrupted, and the tissue around the air sacs (alveoli) becomes scarred and thickened. This makes it more difficult for oxygen to pass into the bloodstream. The disease presents itself with the following symptoms: shortness of breath, nonproductive coughing, fatigue, and weight loss, which tend to develop slowly, over several months. The average rate of survival for someone with this disease is between three and five years.[5] The term ILD is used to distinguish these diseases from obstructive airways diseases.
There are specific types in children, known as children's interstitial lung diseases. The acronym ChILD is sometimes used for this group of diseases.[6]
Prolonged ILD may result in pulmonary fibrosis, but this is not always the case. Idiopathic pulmonary fibrosis is interstitial lung disease for which no obvious cause can be identified (idiopathic) and is associated with typical findings both radiographic (basal and pleural-based fibrosis with honeycombing) and pathologic (temporally and spatially heterogeneous fibrosis, histopathologic honeycombing, and fibroblastic foci).
Interstitial lung disease or ILD is an autoimmune condition of the lung. In some people, the body will attack itself and when it happens in the lung, it is a problem. Once the body begins to attack the lung, you become more short of breath. This video will tell you why.
Where do I get my information from: http://armandoh.org/resource
"Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group of disorders based on similar clinical, radiographic, physiologic, and pathologic changes.
Present primarily with shortness of breath and a non productive cough usually chronic over weeks to months without response to initial treatment of puffers. If there is clinical suspicion of ILD a full pulmonary function test should be done. Characteristic changes of ILD include: reduced total lung capacity (TLC) and DLCO.
The diffuse parenchymal lung diseases are divided into those that are associated with known causes or unknown causes and other weird and wonderful rare causes."
🎥 DON'T JUST WATCH, LEARN ACTIVELY! TRY THE QUIZ! 🤓
https://youmakr.ai/test-playground/questionnaire/673d32a1859b9c170836ea51
👆Hit this quiz and show of your main character aura!
Support me:
🖼️ Buy PDFs: http://armandoh.org/shop
💵 Patreon: http://www.patreon.com/armando
👕 Buy shirts: https://teespring.com/stores/ah-7
Social media:
📷 Instagram: http://instagram.com/armandohasudungan
🐦 Twitter: https://twitter.com/armandohasudung
📔 Facebook: https://www.facebook.com/ArmandoHasudungan
Resources:
📕 Books: http://armandoh.org/resource
🎞️ Equipment: armandoh.org/armando-faigl
You can send me mail:
📫 PO BOX 166, Randwick NSW 2031, Australia
Where do I get my information from: http://armandoh.org/resource
"Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group of disorders based on similar clinical, radiographic, physiologic, and pathologic changes.
Present primarily with shortness of breath and a non productive cough usually chronic over weeks to months without response to initial treatment of puffers. If there is clinical suspicion of ILD a full pulmonary function test should be done. Characteristic changes of ILD include: reduced total lung capacity (TLC) and DLCO.
The diffuse parenchymal lung diseases are divided into those that are associated with known causes or unknown causes and other weird and wonderful rare causes."
🎥 DON'T JUST WATCH, LEARN ACTIVELY! TRY THE QUIZ! 🤓
https://youmakr.ai/test-playground/questionnaire/673d32a1859b9c170836ea51
👆Hit this quiz and show of your main character aura!
Support me:
🖼️ Buy PDFs: http://armandoh.org/shop
💵 Patreon: http://www.patreon.com/armando
👕 Buy shirts: https://teespring.com/stores/ah-7
Social media:
📷 Instagram: http://instagram.com/armandohasudungan
🐦 Twitter: https://twitter.com/armandohasudung
📔 Facebook: https://www.facebook.com/ArmandoHasudungan
Resources:
📕 Books: http://armandoh.org/resource
🎞️ Equipment: armandoh.org/armando-faigl
You can send me mail:
📫 PO BOX 166, Randwick NSW 2031, Australia
An overview of ILD (also known as diffuse parenchymal lung diseases), including definition, classification, etiologies, and diagnostic evaluation (e.g. CT and PFT findings).
This video “Interstitial Lung Disease (ILD): Overview” is part of the Lecturio course “Interstitial Lung Disease” ► WATCH the complete course on http://lectur.io/ildyoutube
► LEARN ABOUT:
- classification of interstital lung disease
► THE PROF: Professor Jeremy Brown is a clinician scientist with an interest in respiratory infection. He studied medicine in London, graduating with honors, and continued his postgraduate medical training in a variety of London hospitals. He completed his PhD in molecular microbiology in 1999 and obtained a prestigious Welcome Advanced Research Fellowship for further scientific training at the University of Adelaide. His research is mainly focused on respiratory complications of haematological disease and stem cell transplantation. His educational and scientific experience enables him to teach students and professionals about respiratory medicine.
►LECTURIO is your single-point resource for medical school:
Study for your classes, USMLE Step 1, USMLE Step 2, MCAT or MBBS with video lectures by world-class professors, recall & USMLE-style questions and textbook articles. Create your free account here: http://lectur.io/ildyoutube
► INSTALL our free Lecturio app
iTunes Store: https://app.adjust.com/z21zrf
Play Store: https://app.adjust.com/b01fak
► READ TEXTBOOK ARTICLES related to this video: Interstitial Lung Disease (ILD) — Types and Symptoms
http://lectur.io/ildarticle
► SUBSCRIBE to our YouTube channel: http://lectur.io/subscribe
► WATCH MORE ON YOUTUBE: http://lectur.io/playlists
► LET’S CONNECT:
• Facebook: https://www.facebook.com/lecturio.medical.education.videos
• Instagram: https://www.instagram.com/lecturio_medical_videos
Please read and agree to the disclaimer before watching this video.
. Subscribe to the drbeen Channel HERE: http://bit.ly/2GBhiS0
For more content from drbeen, click HERE: http://bit.ly/2GB41bU
Watch drbeen videos HERE: http://bit.ly/2GB41bU
Like drbeen on Facebook HERE: http://bit.ly/2GSSTGS
Follow drbeen on Twitter HERE: http://bit.ly/2XeSVhV
Follow drbeen on Instagram HERE: http://bit.ly/2ST2Zih
Get new medical lectures across your devices. Stream anywhere, anytime. Try it for free! http://bit.ly/2QsIwQ5
This video presents the introduction to restrictive lung diseases. We will discuss:
Definition
Types
Extrapulmonary restrictive lung diseases
* Obesity
* Scoliosis
Pulmonary parenchymal restrictive lung diseases
* Idiopathic
* Autoimmune
* Granulomatous (Wagner's granulomatosis, Sarcoidosis)
* Occupational (pneumoconiosis, silicosis, asbestosis, coal, etc.)
* Other irritants
* Chronic infections (Tuberculosis)
Neuromuscular restrictive lung diseases
* Myasthenia gravis
* Diaphragm issues
* Polio
Cellular events/pathogenesis
* Damaged Type I Pneumocytes
* Hypertrophy of Type II Pneumocytes
* Irritated epithelium
* Irritated macrophages
* Apoptosis of epithelium
* Tissue damage leading to local inflammation and lung destruction/scaring.
* Neutrophils releasing cytokines, proteases, tumor growth factors (TGF)
* Macrophages releasing transforming growth factor beta, tumor necrosis factor (TNF), platelet activation factor.
* Fibroblasts overactivity resulting in more extracellular matrix and hardening.
* Epithelial-mesenchymal transformation.
* Smooth muscle proliferation.
* Respiratory interface thickening. Disrupted gaseous exchange.
Clinical:
Dry hacking cough
* Dyspnea
* Hypoxia
* Respiratory alkalosis
* Late inspiratory crackles
Abnormal chest X-Ray
* Reduced volume in chest X-Ray
* Lower lobes show more involvement and the reason why.
* Right heart failure/cor pulmonale
Lung Function Changes
* FEV1/FVC ratio increases above 80% (normal or above normal)
Treatment
* Anti-inflammatory (may not be very effective)
* TGF Beta-blockers
* Oxygen
* Lung transplant ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
.
Chapters
0:00 Introduction
1:18 Causes of Interstitial lung disease
3:13 Symptoms and Diagnosis of Interstitial lung disease
3:53 Treatment of Interstitial lung disease.
Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD),[3] is a group of respiratory diseases affecting the interstitium (the tissue and space around the alveoli (air sacs) of the lungs.[4] It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. It may occur when an injury to the lungs triggers an abnormal healing response. Ordinarily, the body generates just the right amount of tissue to repair damage, but in interstitial lung disease, the repair process is disrupted, and the tissue around the air sacs (alveoli) becomes scarred and thickened. This makes it more difficult for oxygen to pass into the bloodstream. The disease presents itself with the following symptoms: shortness of breath, nonproductive coughing, fatigue, and weight loss, which tend to develop slowly, over several months. The average rate of survival for someone with this disease is between three and five years.[5] The term ILD is used to distinguish these diseases from obstructive airways diseases.
There are specific types in children, known as children's interstitial lung diseases. The acronym ChILD is sometimes used for this group of diseases.[6]
Prolonged ILD may result in pulmonary fibrosis, but this is not always the case. Idiopathic pulmonary fibrosis is interstitial lung disease for which no obvious cause can be identified (idiopathic) and is associated with typical findings both radiographic (basal and pleural-based fibrosis with honeycombing) and pathologic (temporally and spatially heterogeneous fibrosis, histopathologic honeycombing, and fibroblastic foci).
Interstitial lung disease or ILD is an autoimmune condition of the lung. In some people, the body will attack itself and when it happens in the lung, it is a problem. Once the body begins to attack the lung, you become more short of breath. This video will tell you why.
Prolonged ILD may result in pulmonary fibrosis, but this is not always the case. Idiopathic pulmonary fibrosis is interstitial lung disease for which no obvious cause can be identified (idiopathic), and is associated with typical radiographic (basal and pleural based fibrosis with honeycombing) and pathologic (temporally and spatially heterogeneous fibrosis, histopathologic honeycombing and fibroblastic foci) findings.
Causes
ILD may be classified according to the cause. One method of classification is as follows:
In March 2020, the FDA approved nintedanib for treating chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype ... Pneumoconiosis is a type of interstitial lung disease caused by ...
I am a pulmonary physician living in Solon, and I routinely see residents living with a variety of complex lung diseases, including COPD, asthma, interstitial lung disease and lung cancer.
I am a Pulmonary physician living in Solon and I routinely see residents living with a variety of complex lung diseases including COPD, asthma, interstitial lung disease and lung cancer.
... lives of people living with all types of asthma and COPD along with less understood diseases like refractory chronic cough or rarer conditions like systemic sclerosis with interstitial lung disease.
It showed possible signs of mild interstitial lung disease, a progressive condition that causes lung scarring and a dry cough ... Her cough has not recurred; a subsequent CT scan showed no sign of lung disease.
... and the lives of people living with all types of asthma and COPD along with less understood refractory chronic cough or rarer conditions like systemic sclerosis with interstitial lung disease.
Later, at a plant in Rhode Island, several employees who handled nylon flock, which is used to change the texture of some fabrics, developed an interstitial lung disease.
The installation — made of flowers shaped into a pair of lungs — aims at raising awareness about Interstitial Lung Disease (ILD) ... Interstitial Lung Disease encompasses over 200 progressive and often ...
DelveInsight’s “Interstitial Lung DiseaseMarketInsights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Interstitial Lung Disease, ...
No treatment-related interstitial lung disease (ILD) cases were reported. ... Lung cancer claims more lives than any other cancer type and the incidence is set to increase to over 3 million cases ...
While treatment helps control muscle inflammation and skin disease, long-term monitoring is crucial to prevent complications such as interstitial lung disease ... Dermatomyositis DiseaseBackground and Overview.